Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1168264

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1168264

Argentina Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1995
PDF (Site License)
USD 2992
PDF (Global License)
USD 3990

Add to Cart

GlobalData, the industry analysis specialist, has released its latest report "Argentina Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Argentina. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Argentina's pharmaceutical market ranks third in Latin America, after Brazil and Mexico, contributing approximately 11.2% to the Latin American market and 0.5% to the global market at laboratory exit prices. The pharmaceutical market of Argentina in terms of Argentine Pesos (ARS) was worth ARS114 billion in 2017, which increased at a CAGR of 51.9% to reach ARS399 billion in 2020. It is expected to rise even further, reaching 3.2 trillion by 2025. In terms of US dollars, the pharmaceutical market was worth $6.1 billion in 2017, which decreased at a negative CAGR of 8.1% to reach $4.7 billion in 2020. The market value is expected to decrease further, reaching $3.1 billion by 2025. Argentina's medical devices market has grown at a 3.1% CAGR from $4.9 billion in 2016 to $5.8 billion in 2021. It is expected to grow at a CAGR of 1.6% beginning in 2022 and reach $6 billion by 2027. The medical devices market in Argentina is 70-85% import-dependent. It was worth $555 million in 2021. China, the US, and Germany were the top exporters to Argentina in 2021. The Argentine Ministry of Health (MinSalud) approved the "Plan for the Development of Pharmaceutical Services Based on Primary Health Care" on November 10, 2021, through resolution 2949/2021, to support and grade the steps taken by pharmacy professionals for the health and quality of life needs of the population.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Argentina, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi, Bayer, GlaxoSmithKline (GSK), and Roemmers.
  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, Fresenius, GE Healthcare, Terumo, and Coloplast.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
  • Detailed analysis of the country's healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the Argentine healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Indonesian healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Product Code: GDHC0039CHR

Table of Contents

Table of Contents

1. Table of Contents

  • 1.1 List of Figures
  • 1.2 List of Tables

2. Executive Summary

  • 2.1 Executive Summary
  • 2.2 Key Highlights: Facts About the Argentine Healthcare Market
  • 2.3 Key Highlights: Healthcare Startups in Argentina
  • 2.4 Key Events: Argentine Healthcare Timeline, 2016-22
  • 2.5 Key Events: Argentine Pharmaceutical Market
  • 2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2021-22
  • 2.7 Key Events: Top Completed Deals by Value, 2022
  • 2.8 Country Profile, Argentina, 2021

3. Overview of Pharmaceutical Market

  • 3.1 Pharmaceutical Market - Overview
  • 3.2 Pharmaceutical Market - Exports
  • 3.3 Pharmaceutical Market - Imports
  • 3.4 Pharmaceutical Market - Supply Channels, Argentina
  • 3.5 Pharmaceutical Market - Medical Tourism, Argentina
  • 3.6 Pharmaceutical Market - Market Segments
  • 3.7 Pharmaceutical Market - Market Segments, Generics, Argentina
  • 3.8 Pharmaceutical Market - Market Segments, Biologics and Biosimilars, Argentina
  • 3.9 Pharmaceutical Market - Market Segment, Over-the-Counter Medicines, Argentina
  • 3.10 Major Therapeutic Areas, Argentina
  • 3.11 COVID-19 Epidemiology, Argentina
  • 3.12 COVID-19 Impact and Developments in the Healthcare Market, Argentina
  • 3.13 COVID-19 Clinical Trials Landscape, Argentina
  • 3.14 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

  • 4.1 Medical Device Market - Overview
  • 4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

  • 5.1 Drivers
  • 5.2 Barriers

6. Deal Analysis

  • 6.1 Deal Analysis: Pharmaceutical Market, Argentina, 2020-22
  • 6.2 Deal Analysis: Medical Device Market, Argentina, 2020-22

7. Healthtech Landscape

  • 7.1 Healthtech Landscape, Argentina
  • 7.2 Key Healthtech Deals, Argentina
  • 7.3 Adoption of Technology in Healthcare, Argentina
  • 7.4 Digital Healthcare Regulations, Argentina
  • 7.5 Healthtech Landscape: Benefits and Risks, Argentina

8. Market Access

  • 8.1 Overview of Healthcare System, Argentina
  • 8.2 Reimbursement Landscape, Argentina
  • 8.3 Overview of Insurance Providers, Argentina
  • 8.4 Healthcare Spending and Prescription Drug Price Trend, Argentina
  • 8.5 Pricing Policies, Argentina
  • 8.6 Market Access Timeline, Argentina, 2011-22
  • 8.7 Regulatory Landscape, Argentina
    • 8.7.1 Marketing Authorization for Pharmaceutical Products, Argentina
    • 8.7.2 Marketing Authorization for Biologics, Argentina
    • 8.7.3 Marketing Authorization for Medical Devices, Argentina
    • 8.7.4 Intellectual Property Rights, Patents, Argentina
    • 8.7.5 Intellectual Property Rights, Trademarks, Argentina
    • 8.7.6 Clinical Trial Regulation Process, Argentina
    • 8.7.7 Pharmaceutical Clinical Trials Landscape, Argentina
    • 8.7.8 Medical Devices Clinical Trials Landscape, Argentina
    • 8.7.9 Pharmaceutical Import and Export, Argentina
    • 8.7.10 Pharmaceutical Advertising Regulations, Argentina
    • 8.7.11 Pharmacy Regulations, Argentina
    • 8.7.12 Labeling and Packaging Regulations, Argentina

9. Country Healthcare Landscape

  • 9.1 Argentina Healthcare Policy Highlights
  • 9.2 Healthcare Resources and Healthcare Personnel, Argentina
  • 9.3 Life Expectancy and Immunization Rate, Argentina
  • 9.4 Environmental Health, Argentina
  • 9.5 Disease Burden, Argentina
  • 9.6 Healthcare Expenditure, Argentina

10 Trade Associations, Argentina

11 Trade Fairs, Argentina

12 Opportunities and Challenges

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Coverage
    • 13.1.2 Secondary Research
    • 13.1.3 Forecasts
  • 13.2 Bibliography
  • 13.3 About GlobalData
  • 13.4 Contact Us
  • 13.5 Disclaimer
Product Code: GDHC0039CHR

List of Tables

List of Tables

  • Table 1: Research and development investment in pharmaceutical market, Argentina, 2022
  • Table 2: Cost comparison of treatments in the US and Argentina, 2017
  • Table 3: ANMAT-approved biomimics, Argentina, 2022
  • Table 4: ANMAT-approved biosimilars, Argentina, 2022
  • Table 5: Comparison of 12 highest-selling OTC drugs, Argentina, 2021-22
  • Table 6: Comparison of the most sold drugs, Argentina, 2019-20
  • Table 7: COVID-19 indicators (number of cases), Global and Argentina, 2022
  • Table 8: COVID-19-related travel restrictions, Argentina, 2020-22
  • Table 9: Approved COVID-19 vaccines, Argentina, 2022
  • Table 10: Target population to be vaccinated with COVID-19 vaccine as per the updated guideline, Argentina, 2021
  • Table 11: COVID-19 vaccine interchangeability scheme, Argentina, 2021
  • Table 12: Approved additional and booster COVID-19 vaccines, Argentina, 2021
  • Table 13: Medical devices market, major segments ($M), Argentina, 2021
  • Table 14: Copayment values, Argentina, 2022
  • Table 15: Patent approval fees, Argentina, 2022
  • Table 16: Trademark fees, Argentina, 2022
  • Table 17: Trade fairs, Argentina, 2022

List of Figures

List of Figures

  • Figure 1: Pharmaceutical market, revenue [ARS ($B), $B], Argentina, 2017-21
  • Figure 2: Medical devices market, revenue ($B), Argentina, 2016-21
  • Figure 3: Healthcare start-ups in Argentina, 2022
  • Figure 4: Country profile, Argentina, 2021
  • Figure 5: Pharmaceutical market, revenue [ARS ($B), $B], Argentina, 2017-21
  • Figure 6: Pharmaceutical market, revenue forecast [ARS ($B), $B], Argentina, 2022-27
  • Figure 7: Pharmaceutical exports ($M), Argentina, 2014-21
  • Figure 8: Top export partners, Argentina, 2021
  • Figure 9: Pharmaceutical imports ($B), Argentina, 2014-21
  • Figure 10: Top import partners, Argentina, 2021
  • Figure 11: Pharmaceutical supply channel, Argentina, 2022
  • Figure 12: Major local manufacturers on the basis of revenue ($M), Argentina, 2020
  • Figure 13: Facilitators associated with the Argentine Medical Tourism Chamber, Argentina, 2022
  • Figure 14: Hospitals and clinics associated with the Argentine Medical Tourism Chamber, Argentina, 2022
  • Figure 15: Top treatments offered in Argentina, 2022
  • Figure 16: Major generic producing pharmaceutical companies, Argentina, 2022
  • Figure 17: OTC market revenue ($B), Argentina, 2013-21
  • Figure 18: OTC medicines market ($M), major categories, Argentina, 2021
  • Figure 19: Top five therapeutic areas by annual revenue (%), Argentina, 2020
  • Figure 20: COVID-19 cases, Argentina, 2020-22
  • Figure 21: COVID-19 deaths, Argentina, 2020-22
  • Figure 22: COVID-19 stringency index (based on the share of people who are vaccinated), Argentina, 2020-22
  • Figure 23: COVID-19 containment and health index, Argentina, 2020-22
  • Figure 24: COVID-19 fiscal stimulus timeline, Argentina, 2020-22
  • Figure 25: Vaccination plan as per the strategic plan for vaccination, Argentina, 2020
  • Figure 26: COVID-19 vaccine doses administration - number of vaccine doses administered, Argentina, 2020-22
  • Figure 27: Approved additional and booster COVID-19 vaccines, Argentina, 2021
  • Figure 28: COVID-19 clinical trials count by trial status, Argentina, 2021-22
  • Figure 29: COVID-19 clinical trials count by trial phase, Argentina, 2021-22
  • Figure 30: Top COVID-19 clinical trials sponsors by trial count, Argentina, 2021-22
  • Figure 31: Medical devices market, revenue ($B), Argentina, 2016-21
  • Figure 32: Medical devices market, revenue forecast ($B), Argentina, 2022-27
  • Figure 33: Medical devices market, major segments (%), Argentina, 2021
  • Figure 34: Hospital supplies market, revenue ($B), Argentina, 2017-27
  • Figure 35: Cardiovascular devices market, revenue ($M), Argentina, 2017-27
  • Figure 36: General surgery devices market, revenue ($M), Argentina, 2017-27
  • Figure 37: Orthopedic devices market, revenue ($M), Argentina, 2017-27
  • Figure 38: Anesthesia and respiratory devices market, revenue ($M), Argentina, 2017-27
  • Figure 39: Diagnostic market, revenue ($M), Argentina, 2017-21
  • Figure 40: Diagnostic market, revenue forecast ($M), Argentina, 2022-27
  • Figure 41: Medical devices market, revenue ($B) of major companies, Argentina, 2020
  • Figure 42: Deal value and deal count, pharmaceutical market, Argentina, 2020-22
  • Figure 43: Deal value and deal count subtypes, pharmaceutical market, Argentina, 2020-22
  • Figure 44: Deal value and deal count, quarterly, pharmaceutical market, Argentina, 2020-22
  • Figure 45: Top therapy areas by deal value ($M), pharmaceutical market, Argentina, 2020-22
  • Figure 46: Top therapy areas by deal count, pharmaceutical market, Argentina, 2020-22
  • Figure 47: Deal value and deal count, medical devices market, Argentina, 2020-22
  • Figure 48: Deal value and deal count subtypes, medical devices market, Argentina, 2020-22
  • Figure 49: Deal value and deal count, quarterly, medical devices market, Argentina, 2020-22
  • Figure 50: Top equipment sectors by deal value ($M), medical devices market, Argentina, 2020-22
  • Figure 51: Top equipment sectors by deal count, medical devices market, Argentina, 2020-22
  • Figure 52: Phases and activities of National Digital Health Strategy, Argentina, 2018-24
  • Figure 53: Simplified ESB architecture of the National Digital Health Network, Argentina, 2022
  • Figure 54: Principles of National Digital Health Network, Argentina, 2022
  • Figure 55: Overview of healthcare system, Argentina, 2022
  • Figure 56: Medicines covered under the Remediar, Argentina, 2022
  • Figure 57: Process for accessing medicines through Remediar, Argentina, 2022
  • Figure 58: Users of National Social Works and EMP, Argentina, 2022
  • Figure 59: PAMI users, Argentina, 2022
  • Figure 60: OOP expenditure (% of total expenditure on health), Argentina, 2013-22
  • Figure 61: Consumer price index (%), health price index, Argentina, 2018-22
  • Figure 62: Evolution of overall CPI and Health CPI on a monthly basis, Argentina, 2021-22
  • Figure 63: Organization of ANMAT, Argentina, 2022
  • Figure 64: Patent approval process, Argentina, 2022
  • Figure 65: Trademark approval process, Argentina, 2022
  • Figure 66: Clinical trials approved by the ANMAT according to therapeutic area, Argentina, 2017-19
  • Figure 67: Pharmaceutical clinical trials count by trial status, Argentina, 2021-22
  • Figure 68: Pharmaceutical clinical trials count by indication, Argentina, 2021-22
  • Figure 69: Pharmaceutical clinical trials count by phase, Argentina, 2021-22
  • Figure 70: Top five pharmaceutical clinical trials sponsors by count, Argentina, 2021-22
  • Figure 71: Medical device clinical trials count by trial status, Argentina, 2021-22
  • Figure 72: Medical devices clinical trials count by market categories, Argentina, 2021-22
  • Figure 73: Medical devices clinical trials count by therapeutic areas, Argentina, 2021-22
  • Figure 74: Medical devices clinical trials sponsors by count, Argentina, 2021-22
  • Figure 75: Necessary documentation for import of any medicine for personal use, Argentina, 2022
  • Figure 76: Drugs labeling, Argentina, 2022
  • Figure 77: Hospital beds (per 1,000 population), Argentina, 2012-22
  • Figure 78: Physicians (per 1,000 Population), Argentina, 2013-22
  • Figure 79: Nurses (per 1,000 population), Argentina, 2013-22
  • Figure 80: Immunization rate (%), Argentina, 2013-22
  • Figure 81: Life expectancy at birth (years), Argentina, 2013-22
  • Figure 82: PM2.5 (µg per m3), Argentina, 2013-22
  • Figure 83: CO2 emissions (metric tons per capita), Argentina, 2013-22
  • Figure 84: Major causes of mortality (per 100,000 population), Argentina, 2019
  • Figure 85: Major causes of male mortality (per 100,000 population), Argentina, 2019
  • Figure 86: Major causes of female mortality (per 100,000 population), Argentina, 2019
  • Figure 87: DALYs by major disease (per 100,000 population), Argentina, 2019
  • Figure 88: Healthcare expenditure as percentage of GDP (%), Argentina, 2013-22
  • Figure 89: Health expenditure share (% of total health spending), Argentina, 2013-22
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!